These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 16127064

  • 1. Effects of intratracheal administration of novispirin G10 on a rat model of mucoid Pseudomonas aeruginosa lung infection.
    Song Z, Wu H, Mygind P, Raventos D, Sonksen C, Kristensen HH, Høiby N.
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3868-74. PubMed ID: 16127064
    [Abstract] [Full Text] [Related]

  • 2. Effects of Chinese medicinal herbs on a rat model of chronic Pseudomonas aeruginosa lung infection.
    Song Z, Johansen HK, Moser C, Høiby N.
    APMIS; 1996 May; 104(5):350-4. PubMed ID: 8703440
    [Abstract] [Full Text] [Related]

  • 3. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O.
    APMIS Suppl; 2003 May; (116):1-47. PubMed ID: 14692154
    [Abstract] [Full Text] [Related]

  • 4. Augmented effect of early antibiotic treatment in mice with experimental lung infections due to sequentially adapted mucoid strains of Pseudomonas aeruginosa.
    van Gennip M, Moser C, Christensen LD, Bjarnsholt T, Calum H, Jensen PØ, Christophersen L, Hougen HP, Ciofu O, Molin S, Givskov M, Høiby N.
    J Antimicrob Chemother; 2009 Dec; 64(6):1241-50. PubMed ID: 19815632
    [Abstract] [Full Text] [Related]

  • 5. Ginseng treatment enhances bacterial clearance and decreases lung pathology in athymic rats with chronic P. aeruginosa pneumonia.
    Song ZJ, Johansen HK, Faber V, Høiby N.
    APMIS; 1997 Jun; 105(6):438-44. PubMed ID: 9236860
    [Abstract] [Full Text] [Related]

  • 6. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis.
    Pedersen SS.
    APMIS Suppl; 1992 Jun; 28():1-79. PubMed ID: 1449848
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antimicrobial activity of the recombinant designer host defence peptide P-novispirin G10 in infected full-thickness wounds of porcine skin.
    Jacobsen F, Mohammadi-Tabrisi A, Hirsch T, Mittler D, Mygind PH, Sonksen CP, Raventos D, Kristensen HH, Gatermann S, Lehnhardt M, Daigeler A, Steinau HU, Steinstraesser L.
    J Antimicrob Chemother; 2007 Mar; 59(3):493-8. PubMed ID: 17289767
    [Abstract] [Full Text] [Related]

  • 10. Synthetic furanones inhibit quorum-sensing and enhance bacterial clearance in Pseudomonas aeruginosa lung infection in mice.
    Wu H, Song Z, Hentzer M, Andersen JB, Molin S, Givskov M, Høiby N.
    J Antimicrob Chemother; 2004 Jun; 53(6):1054-61. PubMed ID: 15117922
    [Abstract] [Full Text] [Related]

  • 11. In vivo efficacy and pharmacokinetics of tomopenem (CS-023), a novel carbapenem, against Pseudomonas aeruginosa in a murine chronic respiratory tract infection model.
    Morinaga Y, Yanagihara K, Nakamura S, Yamamoto K, Izumikawa K, Seki M, Kakeya H, Yamamoto Y, Yamada Y, Kohno S, Kamihira S.
    J Antimicrob Chemother; 2008 Dec; 62(6):1326-31. PubMed ID: 18835805
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Chronic Pseudomonas aeruginosa lung infection in normal and athymic rats.
    Johansen HK, Espersen F, Pedersen SS, Hougen HP, Rygaard J, Høiby N.
    APMIS; 1993 Mar; 101(3):207-25. PubMed ID: 8507458
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [The establishment of a rat model of chronic pulmonary infection due to Pseudomonas aeruginosa].
    Wang WF, Fang XQ, Liu YN.
    Zhonghua Yi Xue Za Zhi; 2008 Jan 01; 88(1):46-50. PubMed ID: 18346380
    [Abstract] [Full Text] [Related]

  • 16. [Investigation of biofilm formation and relationship with genotype and antibiotic susceptibility of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis].
    Coban AY, Ciftci A, Onuk EE, Erturan Z, Tanriverdi Cayci Y, Durupinar B.
    Mikrobiyol Bul; 2009 Oct 01; 43(4):563-73. PubMed ID: 20084909
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns.
    Steinstraesser L, Tack BF, Waring AJ, Hong T, Boo LM, Fan MH, Remick DI, Su GL, Lehrer RI, Wang SC.
    Antimicrob Agents Chemother; 2002 Jun 01; 46(6):1837-44. PubMed ID: 12019098
    [Abstract] [Full Text] [Related]

  • 19. Expression and antimicrobial function of bactericidal permeability-increasing protein in cystic fibrosis patients.
    Aichele D, Schnare M, Saake M, Röllinghoff M, Gessner A.
    Infect Immun; 2006 Aug 01; 74(8):4708-14. PubMed ID: 16861658
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.